Disparities in prenatal care utilization among u.s. versus foreign-born women with chronic conditions
Methods: We used the 2001 to 2002 NCHS natality files for complete information for the PNCU index and nativity. The dependent variable was PNCU based on the R-GINDEX. Maternal nativity and the presence of a chronic condition (diabetes or hypertensive disorder) were independent variables. We calculated odds ratios for each PNCU group and by chronic condition, using U.S.-born mothers as the reference group.
Results: The proportion of diabetes is higher overall in foreign-born population compared to U.S.-born; for hypertensive disorder, the proportion is higher in U.S.-born. There was evidence of racial differences among foreign-born. Foreign-born women with diabetes had a significantly higher odds of reporting inadequate PNCU (aOR=1.62, 95% CI=1.54-1.71) compared to U.S.-born with the same condition. A similar pattern was observed for women with hypertensive disorders (aOR=1.51, 95% CI=1.44-1.58)
Conclusions: Despite higher proportion of some chronic conditions, foreign-born women with chronic conditions have higher levels of inadequate PNCU compared to U.S.-born women with the same conditions. This study suggests the need for increased PNCU among foreign-born women, especially those with chronic conditions. Further examination of racial and ethnic differences by nativity status is needed.
Learning Areas:Diversity and culture
Public health or related research
Compare racial/ethnic differences in chronic conditions by maternal nativity Identify differences in prenatal care utilization among U.S. and foreign-born women with chronic conditions
Keyword(s): Perinatal Health
Qualified on the content I am responsible for because: This study came from my doctoral-level work done for a perinatal health class where Dr. Martha Wingate served as course instructor.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.